China Post-approval Commitment (PAC) Study of Avalglucosidase Alfa in Participants With IOPD

NCT06666413 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Glycogen Storage Disease Type II
Pompe's Disease

Interventions

DRUG: Avalglucosidase alfa

Sponsor

Genzyme, a Sanofi Company